Core Viewpoint - Guoshin Securities has given a "better than market" rating to Shangmei Co., predicting net profit attributable to shareholders of 1.107 billion, 1.388 billion, and 1.702 billion yuan for 2025-2027, with EPS of 2.78, 3.49, and 4.27 yuan per share respectively, and a target price range of 104.5-120.9 HKD per share [1] Group 1: Company Performance - The company is positioned as a leading domestic beauty brand, leveraging inclusive mechanisms, in-depth R&D, and diverse channels to solidify its performance base through its main brand, Han Shu, which has expanded its product categories and achieved breakthroughs with popular products [1][2] - The main brand Han Shu has achieved significant sales with its Hongman Waist set, ranking first on Douyin's beauty list for eight consecutive months in 2023, and has launched the X Peptide cream to achieve a breakthrough in single product sales [2] Group 2: Market Dynamics - The cosmetics industry has entered a phase of stable growth post-pandemic, with diminishing channel benefits and increasing competition from new brands, leading to a shortened growth lifecycle for single products [1] - Platform-based operational capabilities are crucial for beauty companies to overcome growth bottlenecks, allowing them to adapt to market changes and build a sustainable multi-brand and multi-category business matrix [1] Group 3: Multi-Brand Strategy - The company has developed reusable foundational capabilities in channels, R&D, and marketing, resulting in a platform-based development approach with multiple categories and brands [2] - The company has successfully penetrated niche markets with its multi-brand strategy, including high-end maternal and infant products, anti-hair loss care, and sensitive skin products, contributing to a diverse growth curve [2]

Core Viewpoint - Guosen Securities has given a "better than market" rating to Shangmei Co., predicting net profit attributable to shareholders of 1.107 billion, 1.388 billion, and 1.702 billion yuan for 2025-2027, with EPS of 2.78, 3.49, and 4.27 yuan per share respectively, and a target price of 104.5-120.9 HKD per share [1] Company Summary - Shangmei Co. is positioned as a leading domestic beauty brand, leveraging inclusive mechanisms, in-depth R&D, and diverse channels to solidify its performance base through its main brand, Han Shu, which has expanded its product categories and achieved significant sales through bundled offerings [1] - The company has developed reusable foundational capabilities in channels, R&D, and marketing, leading to a platform-based development model with multiple categories and brands [2] - The main brand Han Shu has achieved breakthroughs with products like the Hongman Waist Set and X Peptide Cream, while also expanding into hair care, men's products, and cosmetics [2] Industry Summary - The cosmetics industry has entered a stable growth phase post-pandemic, with diminishing channel benefits and increasing competition from new brands, resulting in shorter product growth life cycles [1] - Platform-based operational capabilities are crucial for beauty companies to overcome growth bottlenecks, allowing them to adapt to market changes and build a sustainable multi-brand and multi-category business matrix [1] - Companies like Shanghai Jahwa, Proya, and currently Shangmei have successfully established platform systems to achieve sustainable growth through industry fluctuations [1]

Group 1: Heart Disease Medical Devices - Haitong International maintains an "outperform" rating for Xintai Medical, with a target price of HKD 28.94, highlighting its leadership in congenital heart disease intervention devices and a projected revenue growth of 32.4% year-on-year for H1 2025 [1] Group 2: Express Delivery Services - CITIC Securities maintains a "buy" rating for Jitu Express, noting a 23.1% year-on-year increase in parcel volume in Q3, with Southeast Asia's growth rate reaching 78.7%, driven by cost and efficiency advantages [2] - Shenwan Hongyuan also maintains an "accumulate" rating for Jitu Express, reporting a market share increase to 32.8% and a recovery in domestic express delivery prices, despite a downward revision in profit forecasts [3] Group 3: Healthcare and Medical Services - CITIC Jiantou maintains a "buy" rating for China Resources Medical, indicating that while H1 2025 performance may be pressured by declining average medical insurance fees, the company holds a solid regional leadership position [4] - CITIC Jiantou also maintains a "buy" rating for Weitai Medical, projecting a 63.1% year-on-year revenue growth for H1 2025, with significant narrowing of losses and potential for breakeven by year-end [5] Group 4: Consumer Goods and Retail - Guosen Securities maintains an "outperform" rating for Shangmei Co., with a target price of HKD 120.9, emphasizing strong growth in net profit at a compound annual growth rate of 130% from 2022 to 2024 [6] - Huaxin Securities maintains an "accumulate" rating for Nayuki Tea, benefiting from demand catalyzed by Meituan's delivery subsidies and seasonal effects, with improved profitability through product innovation [7] - Huaxin Securities also maintains a "buy" rating for Wugu Mofang, reporting a 14% revenue growth and an 18% net profit increase for H1 2025, driven by strong performance in offline channels [8] Group 5: Food and Beverage - Guangda Securities maintains an "accumulate" rating for Xiaocaiyuan, noting its position as a leading casual dining chain with a customer price range of HKD 50-70, and plans to expand to 1,000 stores by the end of 2026 [10] - Xibu Securities initiates coverage on China Resources Beverages with an "accumulate" rating and a target price of HKD 15, highlighting a market share of 32.7% and improvements in gross margin through increased self-production [11]

Core Viewpoint - The company is building long-term advantages through multi-brand synergy, channel optimization, and increased R&D investment, with strategic implementation showing continuous results [1] Group 1: Brand Strategy and Global Expansion - The company announced Jackson Wang as the global brand ambassador, enhancing its high-end image and international presence [2] - The company has signed popular stars like Ding Yuxi and Tian Xunying, with Tian's first-day sales reaching 50-60 million, indicating strong consumer purchasing power [2] Group 2: Sales Strategy and Product Focus - The company is focusing on profit and core products during the Double Eleven sales event, promoting the X Peptide high-end series and the Hongyun makeup series [3] - The X Peptide series benefits from Jackson Wang's endorsement, while the Hongyun series aligns with the festive season, potentially boosting the makeup segment [3] Group 3: Competitive Advantages - The company has established a strong brand presence and consumer loyalty through extensive marketing during the "big screen exposure era" [4] - The organization employs a "top-tier talent" strategy, attracting high-level professionals and enabling quick responses to online sales platform changes [4] - The company has significant sales volume, enhancing its negotiation power compared to smaller brands, and maintains high gross margins through vertical integration and cost control [4] Group 4: Long-term Growth Strategy - The company achieved an online GMV of 4.5 billion in the first half of 2025, with multiple products exceeding 100 million in sales [5] - Three new brands are set to launch in 2025, with positive performance from skincare and makeup brands, supporting a revenue target of 30 billion by 2030 [5] - The company is expanding globally, with a 300 million investment in Southeast Asia and plans for further expansion into North America and Europe [5]

Core Viewpoint - The company is building long-term advantages through multi-brand collaboration, channel optimization, and increased R&D investment, with strategic implementation showing continuous results [1] Group 1: Brand Strategy - The company announced Jackson Wang as the global brand ambassador, enhancing its high-end image and international presence [2] - The company has signed popular stars like Ding Yuxi and Tian Xunying, with the latter achieving significant sales on the first day of announcement [2] Group 2: Sales Strategy - The company is focusing on profit and core products during the Double Eleven promotion, leveraging partnerships with influencers like Li Jiaqi to promote high-end series [3] - The X peptide series is reinforced by Jackson Wang's endorsement, while the "Red Luck" concept aligns with the festive season, aiming to boost the cosmetics segment [3] Group 3: Competitive Advantages - The company has a strong brand presence and consumer recognition, benefiting from extensive marketing coverage [4] - The organization employs a "top-tier talent" strategy, attracting high-level professionals and enabling quick responses to market changes [4] - The company has significant negotiation power due to its large sales volume, allowing it to secure resources effectively [4] - The supply chain is vertically integrated, enabling rapid product launches and maintaining high profit margins [4] Group 4: Growth Strategy - The company achieved an online GMV of 4.5 billion yuan in the first half of 2025, with multiple products exceeding 100 million yuan in sales [5] - Three new brands are set to launch in 2025, with positive performance from existing brands, supporting a long-term revenue target of 30 billion yuan by 2030 [5] - The company is expanding globally, with a factory investment of 300 million yuan in Southeast Asia and plans for further expansion into North America and Europe [5]

Investment Rating - The report maintains a "Buy" rating for the company [2] Core Insights - The company has announced Wang Jiaer as its global spokesperson, enhancing its brand's global positioning. This partnership is expected to leverage Wang's international fan base and high-end brand associations [2] - The company has shown strong sales performance, with significant revenue generated from collaborations with popular influencers, indicating robust consumer purchasing power [2] - The company is focusing on a multi-brand strategy and global expansion, with plans to enter Southeast Asia and eventually North America and Europe, aiming for a long-term revenue target of 30 billion by 2030 [7] Financial Data and Profit Forecast - Revenue projections for the company are as follows: - 2023: 4,191 million - 2024: 6,793 million - 2025E: 8,513 million - 2026E: 10,641 million - 2027E: 12,786 million - Year-on-year growth rates are projected at 57% for 2023, 62% for 2024, and 25% for 2025 and 2026, with a 20% growth rate expected in 2027 [4] - Net profit forecasts are as follows: - 2023: 461 million - 2024: 781 million - 2025E: 1,149 million - 2026E: 1,496 million - 2027E: 1,806 million - The net profit growth rates are projected at 213% for 2023, 69% for 2024, and 47% for 2025, with 30% and 21% expected for 2026 and 2027 respectively [4] - Earnings per share are expected to increase from 1.16 in 2023 to 4.54 in 2027, with a net asset return rate projected to be 36% in 2025 [4] Strategic Initiatives - The company is implementing a robust strategy for the Double Eleven shopping festival, focusing on high-margin products and leveraging influencer marketing [7] - The company is enhancing its competitive edge through brand development, talent acquisition, and supply chain integration, allowing for rapid product launches and cost control [7] - The multi-brand strategy includes the introduction of new brands and IP collaborations, with a clear path for expansion into various product categories [7]

Core Insights - The men's beauty market is experiencing significant growth, with L'Oréal China aiming to reach 150 million consumers by 2030, particularly targeting males aged 15 and above [1][2] - Men's grooming products have shown explosive growth in 2023, with men's hair care sales soaring by 122.75% and men's foundation sales increasing by 228.78% [1][5] - The competitive landscape is shifting, with traditional brands facing challenges while new entrants like KANS and SAZA are achieving substantial growth [1][12] Market Performance - In the first eight months of 2023, the total transaction value for men's beauty products reached 60.35 billion yuan, reflecting a 10.39% year-on-year increase, with transaction volume up by 33.47% [5][6] - The breakdown of key categories shows men's facial care at 47.35 billion yuan (2.05% growth), men's hair care at 6.75 billion yuan (122.75% growth), men's body care at 3.56 billion yuan (1.61% growth), and men's color cosmetics at 2.69 billion yuan (54.88% growth) [6][7] Consumer Trends - The demand for men's beauty products is evolving from basic grooming to more diverse offerings, including anti-aging serums and makeup products [3][18] - Social media engagement around men's beauty topics is surging, with "men's skincare" videos on Douyin reaching 12.24 billion views and "men's makeup" videos hitting 7.59 billion views [3][4] Brand Dynamics - The top 20 brands in the men's beauty sector are experiencing a divide, with 9 brands showing declining sales, while others like KANS and SAZA are achieving exponential growth [12][16] - L'Oréal, Ocean Supreme, and Left and Right Color are leading the market, with L'Oréal's sales declining by 4.16% while KANS saw a 123.79% increase [11][12] Future Outlook - The men's beauty market is projected to reach 170 billion yuan in 2024, with a compound annual growth rate of 11% expected to push the market to 292 billion yuan by 2029 [3][4] - The competition is intensifying, with brands focusing on product diversification and brand building to capture the evolving consumer preferences [28][29]

Group 1: Market Overview - The Hang Seng Index rose by 1.21%, gaining 308 points to close at 25,749 points, while the Hang Seng Tech Index increased by 1.18% [1] - Hong Kong's stock market saw a trading volume of HKD 158.6 billion in the morning session [1] Group 2: Airline Sector - Airline stocks experienced a collective rise, with growth in passenger traffic during the National Day holiday despite high base effects, indicating potential profit growth for airlines [1] - Eastern Airlines (00670) increased by 5.43%, China National Aviation (00753) rose by 4.06%, and Southern Airlines (01055) gained 3.74% [1] Group 3: Cement Sector - Cement stocks led the market gains, with a rebound expected in prices following a recent decline in several domestic markets [1] - China National Building Material (03323) rose by 6.32%, Conch Cement (00914) increased by 4.13%, and Huaxin Cement (06655) gained 3.78% [1] Group 4: Gold Sector - Lao Pu Gold (06181) surged over 7% as Morgan Stanley reaffirmed its "overweight" rating, citing a clear trend in brand value enhancement [1] - China Rare Earth Holdings (03788) rose over 5% as it completed pre-IPO fundraising and is set to list independently in Hong Kong [1] Group 5: Food and Beverage Sector - Guoquan (02517) saw a rise of over 9% as the restaurant sector's outlook improved, with expectations for store openings in Q4 [2] - Mixue Group (02097) increased by over 6%, with the brand gaining popularity and institutions optimistic about its brand expansion [4] Group 6: Consumer Goods Sector - Pop Mart (09992) rose by 3.6%, with potential to become a world-class cultural IP brand following a special gift to Apple's CEO [3] - Shangmei Co. (02145) increased by over 6%, with strong performance in domestic beauty brands in September and expectations for marginal improvement in Q4 due to the Double 11 shopping festival [3] Group 7: Gold Mining Sector - Shandong Gold (01787) fell over 5% after a profit warning, despite a potential doubling of net profit year-on-year for the first three quarters, with institutions advising caution regarding short-term adjustments in gold prices [5]

Group 1 - The core viewpoint of the article highlights the significant growth in the beauty sector on Douyin, with the top 20 beauty brands achieving a total GMV of over 3 billion yuan in September 2025, representing a market share of 17.6% and a year-on-year growth of 38.59% [1] - The article notes that the GMV for beauty products on Douyin increased by 19.7% year-on-year in September 2025, although it experienced a quarter-on-quarter decline of 10.4% [1] - Domestic brands are showing strong performance in self-operated sales, with 60% of the top 20 beauty brands having a higher GMV contribution from self-operated channels than from influencer promotions, and brands like Han Shu and Pechoin having over 70% of their GMV from self-operated sales [1] Group 2 - According to Zheshang Securities, new consumer brands in the cosmetics sector are expected to maintain a compound annual growth rate of 20%-30% in revenue and profit over the next 2-3 years, indicating continued attractiveness and certainty in the market [1] - The Q3 performance is described as weak due to seasonal factors, with some companies experiencing a slowdown in revenue growth. The increase in costs related to the upcoming Double Eleven shopping festival is expected to impact profit performance negatively compared to revenue [1] - The article predicts that brands like Maogeping and Shangmei will outperform the industry in terms of performance [1]

Core Viewpoint - The new consumption concept stocks in Hong Kong have shown a significant upward trend, indicating positive market sentiment and potential growth in this sector [1]. Group 1: Stock Performance - Shangmei Holdings (02145.HK) increased by 7.43%, reaching HKD 101.2 [1] - Guming (01364.HK) rose by 7.33%, trading at HKD 26.08 [1] - Mixue Group (02097.HK) saw a gain of 6.53%, priced at HKD 443.8 [1] - Miniso (09896.HK) climbed by 5.15%, with a share price of HKD 45.32 [1] - Blukoo (00325.HK) experienced a 4.99% increase, valued at HKD 107.4 [1] - Laopu Gold (06181.HK) grew by 4.04%, trading at HKD 721 [1]